Market Overview:
The global iodixanol injection market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of renal diseases, rising geriatric population, and technological advancements in the field of medical devices. Additionally, growing demand for minimally invasive surgeries is also propelling the growth of this market. Based on type, the global iodixanol injection market is segmented into 150 mg I/mL, 270 mg I/mL, 320 mg I/mL and others. The 150 mg I/mL segment dominates this market owing to its low cost and easy availability as compared to other types available in the market. Based on application, hospitals account for a major share of this market owing to increasing number of surgical procedures being performed in hospitals across the globe.
Product Definition:
Iodixanol Injection is a radiocontrast agent used to enhance the visibility of internal structures during medical imaging procedures. It is injected into a vein and travels throughout the body, allowing doctors to see detailed images of organs and tissues. Iodixanol Injection is used to diagnose and treat a variety of medical conditions.
150 mg I/mL:
150 mg I/mL is a sterile solution of iodine and ethanol, used for the treatment of thyroid-related disorders such as goiter. It works by blocking the production of thyroid hormones.
Iodixanol injection has been prescribed for patients who are unresponsive to oral medications or those who have developed severe side effects due to them.
270 mg I/mL:
Iodixanol is a prescription medicine used to treat urinary tract infections. The active ingredient in the drug is called as iodic acid. It works by killing the bacteria that causes infection in the urinary system.
Application Insights:
The global iodine injection market is categorized based on application into hospitals, clinics and others. The hospitals segment dominated the market in 2017 due to factors such as increasing healthcare spending by governments, growing prevalence of chronic diseases and high birth rate. Moreover, a rise in cancer cases has also resulted in an increased demand for diagnostic procedures which will further boost the growth of this segment over the forecast period.
Iodixanol injections are used for various conditions such as hypothyroidism (underactive thyroid), hyperthyroidism (overactive thyroid) and goitre (enlargement of the thyroid gland). Hyperthyroidism is a common condition that affects women more than men; around 4 out of 10 people suffering from hyperthyroidism are female.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement scenario, and high adoption rate for new technologies are some of the major factors responsible for its large share. Moreover, increasing cases of cancer is also expected to drive this regional market over the forecast period. For instance, as per American Cancer Society (ACS), Inc., in 2018 around 2 million people will be diagnosed with cancer in North America and about 1 million people will die from it.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments & private sectors coupled; With growing awareness regarding iodixanol injection among physicians & other healthcare professionals; Increasing prevalence of chronic diseases like diabetes which necessitates regular I/M therapy injections; And last but not least rapid economic development witnessed by countries like India.
Growth Factors:
- Increasing demand for minimally invasive surgeries: Iodixanol injection is used as a contrast medium in various minimally invasive surgeries such as percutaneous coronary intervention (PCI), percutaneous transluminal angioplasty (PTA), and endovascular aneurysm repair (EVAR). The increasing demand for minimally invasive surgeries is expected to drive the growth of the iodixanol injection market.
- Rising prevalence of cardiovascular diseases: The prevalence of cardiovascular diseases is increasing globally due to changing lifestyle and dietary habits. This has led to an increase in the number of patients requiring PCI, PTA, and EVAR procedures, which in turn is driving the growth of the iodixanol injection market.
- Technological advancements in interventional cardiology: There have been significant advancements in interventional cardiology techniques over the past few years, which has resulted in increased use of iodixanol injection as a contrast medium during these procedures. This is expected to boost the growth of the iodixanol injection market during forecast period.
- Growing geriatric population: The global geriatric population is growing at a rapid pace and this trend is particularly prominent in developed countries such as Japan, Germany, and France owing to declining fertility rates and longer life expectancies among people aged 65 years or above In addition, elderly patients are more prone to developing cardiovascular diseases than younger individuals; thus there will be an increased demand for PCI procedures among
Scope Of The Report
Report Attributes
Report Details
Report Title
Iodixanol Injection Market Research Report
By Type
150 mg I/mL, 270 mg I/mL, 320 mg I/mL, Others
By Application
Hospitals, Clinics
By Companies
GE Healthcare, Hengrui Medicine, Daiichi Sankyo, YRPG, BeiLu Pharma, Cadiasun Pharma GmbH, GE Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Iodixanol Injection Market Report Segments:
The global Iodixanol Injection market is segmented on the basis of:
Types
150 mg I/mL, 270 mg I/mL, 320 mg I/mL, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Hengrui Medicine
- Daiichi Sankyo
- YRPG
- BeiLu Pharma
- Cadiasun Pharma GmbH
- GE Healthcare
Highlights of The Iodixanol Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 150 mg I/mL
- 270 mg I/mL
- 320 mg I/mL
- Others
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Iodixanol Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Iodixanol injection is a medication used to treat pain and inflammation. It is a type of opioid drug. Iodixanol injection is given as an intravenous (into the vein) or intramuscular (into the muscle) injection.
Some of the major companies in the iodixanol injection market are GE Healthcare, Hengrui Medicine, Daiichi Sankyo, YRPG, BeiLu Pharma, Cadiasun Pharma GmbH, GE Healthcare.
The iodixanol injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Iodixanol Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Iodixanol Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Iodixanol Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Iodixanol Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Iodixanol Injection Market Size & Forecast, 2018-2028
4.5.1 Iodixanol Injection Market Size and Y-o-Y Growth
4.5.2 Iodixanol Injection Market Absolute $ Opportunity
Chapter 5 Global Iodixanol Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Iodixanol Injection Market Size Forecast by Type
5.2.1 150 mg I/mL
5.2.2 270 mg I/mL
5.2.3 320 mg I/mL
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Iodixanol Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Iodixanol Injection Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Iodixanol Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Iodixanol Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Iodixanol Injection Analysis and Forecast
9.1 Introduction
9.2 North America Iodixanol Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Iodixanol Injection Market Size Forecast by Type
9.6.1 150 mg I/mL
9.6.2 270 mg I/mL
9.6.3 320 mg I/mL
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Iodixanol Injection Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Iodixanol Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Iodixanol Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Iodixanol Injection Market Size Forecast by Type
10.6.1 150 mg I/mL
10.6.2 270 mg I/mL
10.6.3 320 mg I/mL
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Iodixanol Injection Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Iodixanol Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Iodixanol Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Iodixanol Injection Market Size Forecast by Type
11.6.1 150 mg I/mL
11.6.2 270 mg I/mL
11.6.3 320 mg I/mL
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Iodixanol Injection Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Iodixanol Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Iodixanol Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Iodixanol Injection Market Size Forecast by Type
12.6.1 150 mg I/mL
12.6.2 270 mg I/mL
12.6.3 320 mg I/mL
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Iodixanol Injection Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Iodixanol Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Iodixanol Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Iodixanol Injection Market Size Forecast by Type
13.6.1 150 mg I/mL
13.6.2 270 mg I/mL
13.6.3 320 mg I/mL
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Iodixanol Injection Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Iodixanol Injection Market: Competitive Dashboard
14.2 Global Iodixanol Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Hengrui Medicine
14.3.3 Daiichi Sankyo
14.3.4 YRPG
14.3.5 BeiLu Pharma
14.3.6 Cadiasun Pharma GmbH
14.3.7 GE Healthcare
